Endopap-versus Pipelle-sampling in the diagnosis of postmenopausal endometrial disease

Eur J Obstet Gynecol Reprod Biol. 1996 Jan;64(1):91-4. doi: 10.1016/0301-2115(95)02274-0.

Abstract

Objective: To evaluate the accuracy of Endopap- and Pipelle-sampling in the diagnosis of postmenopausal disease.

Study design: Observational study in the setting of a University Hospital. One hundred and six consecutive postmenopausal women presenting with uterine bleeding or endometrial cells on cervical cytology underwent an Endopap sampling as well as a Pipelle biopsy. Thereafter, 89 of those women underwent a hysteroscopy and curettage (n = 71) or a hysterectomy (n = 18). The diagnostic accuracy of Pipelle and Endopap was assessed against the final diagnosis.

Results: Endometrial carcinoma was found in five cases (6%), benign disease in 34 (38%). The sensitivity of Endopap and Pipelle for the detection of endometrial disease was 56 and 51%, respectively, with a specificity of 94 and 100%, respectively. The sensitivity for endometrial carcinoma was 80% for Endopap and 100% for Pipelle.

Conclusions: Our data tend to favor Pipelle against Endopap as diagnostic tool in endometrial disease in symptomatic postmenopausal women.

Publication types

  • Comparative Study

MeSH terms

  • Biopsy / instrumentation*
  • Diagnosis, Differential
  • Endometrial Neoplasms / complications
  • Endometrial Neoplasms / pathology*
  • Endometrium / pathology*
  • Female
  • Humans
  • Postmenopause*
  • Sensitivity and Specificity
  • Uterine Diseases / complications
  • Uterine Diseases / pathology*
  • Uterine Hemorrhage / etiology